We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

FDA Approves ACTEMRA® for the Treatment of Moderately to Severely Active Rheumatoid Arthritis

News   Jan 11, 2010

 
FDA Approves ACTEMRA® for the Treatment of Moderately to Severely Active Rheumatoid Arthritis
 
 
 

RELATED ARTICLES

Blood Protein Protects against Neuronal Damage after Brain Hemorrhage

News

Researchers have discovered a protein that can protect against brain damage after a hemorrhage.

READ MORE

"Missing" Virus Detected in Children With Polio-like Paralysis

News

Study is first to find clear signs of enterovirus in the nervous system of AFM patients, providing the strongest evidence to date that the disease is viral.

READ MORE

British Columbia’s HPV Vaccination Program Reduces Cervical Pre-cancer Rates by > 50%

News

British Columbia’s school-based human papillomavirus (HPV) immunization program is reducing rates of cervical pre-cancer in B.C. women, according to a new study.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE